Neurological disorders following the use of tumor necrosis factor-α inhibitors in inflammatory bowel disease patients: a real-world pharmacovigilance analysis.
Yi ZhaoZelin LiKanghuai ZhangNa WangPublished in: Expert opinion on drug safety (2024)
Neurological signals were detected for TNFi use, indicating that the risk of neurological AEs requires additional attention in clinical use of TNFis.